Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

Tricuspid Regurgitation Functional clinical trials

2 of 2 indexed Tricuspid Regurgitation Functional trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Tricuspid Regurgitation Functional: 2 US clinical trials tracked, 2 recruiting.

Tricuspid Regurgitation Functional is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Innoventric, running 1 of these trials.

Enrollment posture brief

Registry condition tricuspid-regurgitation-functional

OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Tricuspid Regurgitation (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Tricuspid Regurgitation Functional

Tricuspid Regurgitation Functional lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Tricuspid Regurgitation Functional on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Tricuspid Regurgitation Functional is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Innoventric 1 trials
Cardiac Implants 1 trials

Named interventions

Most-linked intervention names on Tricuspid Regurgitation Functional records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Trillium™ Device
1 trials
CI Percutaneous Ring Annuloplasty System Device
1 trials

US sites by state

Facility locations filed on Tricuspid Regurgitation Functional trials. A trial with sites in several states counts in each.

New York 2 trials
Washington 1 trials
Tennessee 1 trials
Pennsylvania 1 trials
Ohio 1 trials
New Jersey 1 trials
Minnesota 1 trials
Michigan 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Tricuspid Regurgitation Functional page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Tricuspid Regurgitation Functional trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Innoventric sponsors the most Tricuspid Regurgitation Functional trials on record, review their full trial history before evaluating a specific study. See Innoventric's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tricuspid Regurgitation Functional condition card totals 2 registered trials; most-linked intervention Trillium™; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.